Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Alvimopan improves gastrointestinal transit in POI and chronic constipation

May 25, 2004

Prostaglandins suggested as a potential target in ulcerative colitis

May 25, 2004

Therapeutic benefits of adalimumab in Crohn's disease

May 24, 2004

Potential benefits of SLV-317 in irritable bowel syndrome

May 24, 2004

SciClone meets enrollment objective in phase III hepatitis C trial

May 24, 2004

JYL-1421 and acid stimulation of esophageal afferent neurons in rats

May 24, 2004

Preliminary evidence for the efficacy of basiliximab in ulcerative colitis

May 21, 2004

Positive results reported from phase III trial of alvimopan in opioid-induced bowel dysfunction

May 21, 2004

Therapeutic benefits of sargramostim in moderate to severe Crohn's disease

May 21, 2004

Phase II clinical data on the efficacy of tolevamer in CDAD

May 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...